# SUGP2

## Overview
SUGP2 (SURP and G-patch domain containing 2) is a gene that encodes a protein involved in the critical biological process of RNA splicing. The protein, characterized by the presence of SURP and G-patch domains, is primarily active in the nucleus, where it plays a significant role in the maturation and regulation of mRNA. As a member of the arginine/serine-rich family of splicing factors, the SUGP2 protein is essential for proper mRNA processing, influencing gene expression and cellular function. It is particularly involved in spermatogenesis and is expressed in tissues such as the testis and brain, suggesting roles in neurodevelopment and reproductive biology (Zhan2021ChromatinAssociated; Du2023PCDH1; Shimada2023De). The protein's interactions with other nuclear components and its involvement in alternative splicing underscore its importance in maintaining genomic stability and its potential implications in various diseases, including cancer and myelodysplasia (Kosar2021The; Pellagatti2018Impact).

## Function
SUGP2 (SURP and G-patch domain containing 2) is a gene that encodes a protein involved in RNA splicing, a critical process in gene expression where introns are removed from pre-mRNA. The protein contains SURP and G-patch domains, which are implicated in RNA binding and interaction with other splicing factors. SUGP2 is active in the nucleus, where it contributes to the regulation of mRNA maturation, impacting cellular functions and organismal development.

The SUGP2 protein is a member of the arginine/serine-rich family of splicing factors, playing a crucial role in mRNA processing. This function is essential for the regulation of gene expression, as it influences the maturation and stability of mRNA transcripts (Shimada2023De). In healthy human cells, SUGP2 is primarily involved in RNA processing and spermatogenesis, indicating its role in both general cellular functions and specific biological processes (Du2023PCDH1).

SUGP2 is also expressed in the testis and brain, suggesting its involvement in processes beyond splicing, potentially related to neurodevelopment and reproductive biology (Zhan2021ChromatinAssociated). The protein's activity in the nucleus aligns with its role in mRNA splicing, where it likely interacts with other nuclear components to facilitate the precise removal of introns from pre-mRNA.

## Clinical Significance
Mutations and alterations in the SUGP2 gene have been implicated in various diseases, particularly cancer. In muscle-invasive bladder cancer (MIBC), SUGP2 was identified as having recurrent mutations, specifically two missense mutations predicted to be damaging. These mutations suggest that abnormal mRNA processing may contribute to carcinogenesis in bladder cancer (Zhao2016Wholeexome). 

SUGP2 is also involved in a network of proteins that interact with the nucleoporin Tpr, which is crucial for maintaining genomic stability. Disruption of this network, including changes in SUGP2 interactions, can lead to transcription-dependent replication stress, which is linked to cancer (Kosar2021The). 

In myelodysplasia (MDS), SUGP2 is one of the genes commonly aberrantly spliced due to mutations in splicing factor genes such as SF3B1, SRSF2, and U2AF1. These aberrant splicing events can lead to dysregulated gene expression, potentially contributing to the pathogenesis of MDS (Pellagatti2018Impact). 

SUGP2's role in alternative splicing regulation has been highlighted in studies showing that its depletion affects the splicing of numerous mRNAs, indicating its potential involvement in early mRNA processing and its clinical significance in diseases related to splicing dysregulation (Memet2024Insights).

## Interactions
SUGP2 is involved in various interactions with proteins and nucleic acids, playing a significant role in RNA processing. It is a chromatin-associated protein that participates in mRNA alternative splicing during mouse spermatogenesis, indicating its involvement in the regulation of gene expression (Zhan2021ChromatinAssociated). SUGP2 is part of a network of proteins interacting with the human nucleoporin Tpr, which is crucial for protecting cells from RNA-mediated replication stress. The depletion of SUGP2, along with other Tpr interactors like PTBP1 and MATR3, leads to replication stress-sensitive phenotypes, suggesting that SUGP2 is involved in an RNA processing pathway that maintains genomic stability (Kosar2021The).

SUGP2 may also interact with PTBP1 through potential PRI motifs, although this interaction has not been experimentally confirmed (Coelho2016Functional). Additionally, SUGP2 is implicated in binding specific repetitive RNA elements, such as (GUU)n repeats, highlighting its role in RNA-protein interactions (Boyle2022Skipper). These interactions underscore SUGP2's involvement in complex regulatory networks essential for RNA processing and cellular function.


## References


[1. (Coelho2016Functional) Miguel B. Coelho, David B. Ascher, Clare Gooding, Emma Lang, Hannah Maude, David Turner, Miriam Llorian, Douglas E.V. Pires, Jan Attig, and Christopher W.J. Smith. Functional interactions between polypyrimidine tract binding protein and pri peptide ligand containing proteins. Biochemical Society Transactions, 44(4):1058–1065, August 2016. URL: http://dx.doi.org/10.1042/bst20160080, doi:10.1042/bst20160080. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/bst20160080)

[2. (Zhao2016Wholeexome) Junjie Zhao, Weidong Xu, Minghui He, Zhensheng Zhang, Shuxiong Zeng, Chong Ma, Yinghao Sun, and Chuanliang Xu. Whole-exome sequencing of muscle-invasive bladder cancer identifies recurrent copy number variation in ipo11 and prognostic significance of importin-11 overexpression on poor survival. Oncotarget, 7(46):75648–75658, September 2016. URL: http://dx.doi.org/10.18632/oncotarget.12315, doi:10.18632/oncotarget.12315. This article has 8 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.12315)

3. (Boyle2022Skipper) Skipper analysis of RNA-protein interactions highlights depletion of genetic variation in translation factor binding sites. This article has 1 citations.

[4. (Pellagatti2018Impact) Andrea Pellagatti, Richard N. Armstrong, Violetta Steeples, Eshita Sharma, Emmanouela Repapi, Shalini Singh, Andrea Sanchi, Aleksandar Radujkovic, Patrick Horn, Hamid Dolatshad, Swagata Roy, John Broxholme, Helen Lockstone, Stephen Taylor, Aristoteles Giagounidis, Paresh Vyas, Anna Schuh, Angela Hamblin, Elli Papaemmanuil, Sally Killick, Luca Malcovati, Marco L. Hennrich, Anne-Claude Gavin, Anthony D. Ho, Thomas Luft, Eva Hellström-Lindberg, Mario Cazzola, Christopher W. J. Smith, Stephen Smith, and Jacqueline Boultwood. Impact of spliceosome mutations on rna splicing in myelodysplasia: dysregulated genes/pathways and clinical associations. Blood, 132(12):1225–1240, September 2018. URL: http://dx.doi.org/10.1182/blood-2018-04-843771, doi:10.1182/blood-2018-04-843771. This article has 207 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2018-04-843771)

[5. (Kosar2021The) Martin Kosar, Michele Giannattasio, Daniele Piccini, Apolinar Maya-Mendoza, Francisco García-Benítez, Jirina Bartkova, Sonia I. Barroso, Hélène Gaillard, Emanuele Martini, Umberto Restuccia, Miguel Angel Ramirez-Otero, Massimiliano Garre, Eleonora Verga, Miguel Andújar-Sánchez, Scott Maynard, Zdenek Hodny, Vincenzo Costanzo, Amit Kumar, Angela Bachi, Andrés Aguilera, Jiri Bartek, and Marco Foiani. The human nucleoporin tpr protects cells from rna-mediated replication stress. Nature Communications, June 2021. URL: http://dx.doi.org/10.1038/s41467-021-24224-3, doi:10.1038/s41467-021-24224-3. This article has 24 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-021-24224-3)

[6. (Du2023PCDH1) Xingyi Du, Xiaoyu Yi, Xiaocui Zou, Yuan Chen, Yanhong Tai, Xuhong Ren, and Xinhua He. Pcdh1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy. BMC Cancer, November 2023. URL: http://dx.doi.org/10.1186/s12885-023-11474-1, doi:10.1186/s12885-023-11474-1. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-023-11474-1)

7. (Memet2024Insights) Insights into the regulation of RNA helicases by protein cofactors. This article has 0 citations.

[8. (Zhan2021ChromatinAssociated) Junfeng Zhan, Jianbo Li, Yuerong Wu, Panfeng Wu, Ziqi Yu, Peng Cui, Mofan Zhou, Yumin Xu, Tingyu Jin, Ziye Du, Mengcheng Luo, and Cong Liu. Chromatin-associated protein sugp2 involved in mrna alternative splicing during mouse spermatogenesis. Frontiers in Veterinary Science, October 2021. URL: http://dx.doi.org/10.3389/fvets.2021.754021, doi:10.3389/fvets.2021.754021. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fvets.2021.754021)

9. (Shimada2023De) De novo mutations in bipolar disorder implicate neurodevelopment, immunity, and synaptic signaling. This article has 0 citations.